Old Web
English
Sign In
Acemap
>
authorDetail
>
Yi Tao
Yi Tao
Guangzhou Medical University
Adalimumab
Ankylosing spondylitis
Medicine
Internal medicine
Confidence interval
2
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 study.
2021
Clinical Rheumatology
Jinmei Su
Mengtao Li
Lan He
Dongbao Zhao
Weiguo Wan
Yi Liu
Jianhua Xu
Jian Xu
Huaxiang Liu
Lindi Jiang
Huaxiang Wu
Xiaoxia Zuo
Cibo Huang
Xiumei Liu
Fen Li
Zhiyi Zhang
Xiangyuan Liu
Lingli Dong
Tianwang Li
Haiying Chen
Jingyang Li
Dongyi He
Xin Lu
Anbin Huang
Yi Tao
Yanyan Wang
Zhuoli Zhang
Wei Wei
Xiaofeng Li
Xiaofeng Zeng
Show All
Source
Cite
Save
Citations (0)
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial
2020
BioDrugs
Jinmei Su
Mengtao Li
Lan He
Dongbao Zhao
Wei-Guo Wan
Yi Liu
Jianhua Xu
Jian Xu
Hua-Xiang Liu
Lindi Jiang
Huaxiang Wu
Xiaoxia Zuo
Cibo Huang
Xiumei Liu
Fen Li
Zhiyi Zhang
Xiangyuan Liu
Lingli Dong
Tianwang Li
Haiying Chen
Jingyang Li
Dongyi He
Xin Lu
Anbin Huang
Yi Tao
Yanyan Wang
Zhuoli Zhang
Wei Wei
Xiaofeng Li
Xiaofeng Zeng
Show All
Source
Cite
Save
Citations (8)
1